Accretion Pharmaceuticals Limited (NSE:ACCPL)
India flag India · Delayed Price · Currency is INR
67.30
+3.20 (4.99%)
At close: Jan 22, 2026

Accretion Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
1.560.510.920.363.75
Cash & Short-Term Investments
1.560.510.920.363.75
Cash Growth
--44.60%151.92%-90.28%-
Accounts Receivable
218.48116.6158.0557.9940.68
Other Receivables
-7.889.85--
Receivables
241.62124.8668.5857.9940.68
Inventory
228.35206.1144.7677.6469.33
Other Current Assets
28.942.795.719.295.05
Total Current Assets
500.47334.25219.96145.28118.8
Property, Plant & Equipment
86.6738.636.2960.1258.36
Other Long-Term Assets
2.425.1418.140.390.26
Total Assets
590.75398.74274.39205.8177.41
Accounts Payable
22.6318.3916.478.567.37
Accrued Expenses
-0.730.220.150.13
Short-Term Debt
71.1193.941.5637.422.26
Current Portion of Long-Term Debt
-35.4624.1118.5924.83
Current Income Taxes Payable
-25.9918.60.60.25
Other Current Liabilities
21.3857.7949.463.052.47
Total Current Liabilities
115.12232.26150.34138.28117.31
Long-Term Debt
7.4511.6869.1128.6728.99
Pension & Post-Retirement Benefits
---0.440.34
Long-Term Deferred Tax Liabilities
2.41.950.01-0.020.02
Other Long-Term Liabilities
----0
Total Liabilities
124.96245.88219.46167.37146.65
Common Stock
111.1681.74038.4330.76
Retained Earnings
354.6371.1714.93--
Shareholders' Equity
465.79152.8754.9338.4330.76
Total Liabilities & Equity
590.75398.74274.39205.8177.41
Total Debt
78.56141.04134.7884.6676.08
Net Cash (Debt)
-77-140.53-133.86-84.29-72.33
Net Cash Per Share
-8.33-17.53-17.61--
Filing Date Shares Outstanding
10.318.178.17--
Total Common Shares Outstanding
10.318.177.6--
Working Capital
385.3510269.6271.49
Book Value Per Share
45.1818.717.23--
Tangible Book Value
465.79152.8754.9338.4330.76
Tangible Book Value Per Share
45.1818.717.23--
Land
-4.84.84.84.8
Buildings
---21.0220.12
Machinery
-43.7833.7351.6441.54
Source: S&P Global Market Intelligence. Standard template. Financial Sources.